Exeter Financial LLC raised its position in shares of Clorox Co (NYSE:CLX) by 3.9% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 9,719 shares of the company’s stock after purchasing an additional 367 shares during the quarter. Exeter Financial LLC’s holdings in Clorox were worth $1,314,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Cornerstone Wealth Management LLC bought a new position in Clorox in the 2nd quarter worth $105,000. Ostrum Asset Management bought a new position in Clorox in the 1st quarter worth $112,000. Fort L.P. bought a new position in Clorox in the 2nd quarter worth $129,000. Whittier Trust Co. of Nevada Inc. raised its holdings in Clorox by 1,297.4% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock worth $148,000 after purchasing an additional 1,505 shares in the last quarter. Finally, IMS Capital Management bought a new position in Clorox in the 2nd quarter worth $161,000. 78.07% of the stock is owned by institutional investors and hedge funds.

CLX has been the subject of several research reports. ValuEngine upgraded shares of Clorox from a “hold” rating to a “buy” rating in a report on Saturday. BMO Capital Markets restated a “buy” rating and issued a $153.00 price objective on shares of Clorox in a report on Friday, August 3rd. Atlantic Securities assumed coverage on shares of Clorox in a research note on Thursday. They issued a “neutral” rating and a $151.00 price target for the company. Bank of America increased their price target on shares of Clorox from $130.00 to $140.00 and gave the stock a “neutral” rating in a research note on Monday, July 16th. Finally, UBS Group assumed coverage on shares of Clorox in a research note on Wednesday, July 18th. They issued a “sell” rating and a $110.00 price target for the company. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $131.79.

Shares of Clorox stock opened at $152.47 on Monday. The company has a debt-to-equity ratio of 3.15, a current ratio of 1.09 and a quick ratio of 0.67. The stock has a market capitalization of $19.47 billion, a P/E ratio of 24.36, a price-to-earnings-growth ratio of 3.16 and a beta of 0.35. Clorox Co has a 1 year low of $113.57 and a 1 year high of $153.38.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 2nd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.58 by $0.08. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.72 billion. Clorox had a net margin of 13.44% and a return on equity of 103.18%. Clorox’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period last year, the business earned $1.53 EPS. equities research analysts expect that Clorox Co will post 6.41 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 16th. Shareholders of record on Wednesday, October 31st will be paid a dividend of $0.96 per share. The ex-dividend date is Tuesday, October 30th. This represents a $3.84 dividend on an annualized basis and a yield of 2.52%. Clorox’s dividend payout ratio is currently 61.34%.

In other Clorox news, EVP Laura Stein sold 12,880 shares of the firm’s stock in a transaction dated Friday, August 31st. The shares were sold at an average price of $144.10, for a total transaction of $1,856,008.00. Following the completion of the sale, the executive vice president now directly owns 74,483 shares in the company, valued at approximately $10,733,000.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Michael R. Costello sold 9,265 shares of the firm’s stock in a transaction dated Monday, August 13th. The shares were sold at an average price of $140.02, for a total transaction of $1,297,285.30. Following the sale, the senior vice president now owns 34,293 shares of the company’s stock, valued at $4,801,705.86. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 29,268 shares of company stock valued at $4,196,686. 1.00% of the stock is owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Recommended Story: Is the Dow Jones Industrial Average (DJIA) still relevant?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.